MAPK1 and cancer: Even though the KRAS mutation does not have any anti-KRAS therapy and is considered undruggable, certain inhibitors have been shown to be effective against cancer. One of the most effective ways to prevent KRAS mutations is to block the RAF-MEK-ERK protein kinase pathway.